Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
4.640
+0.260 (5.94%)
At close: Oct 8, 2026, 4:00 PM EDT
4.520
-0.120 (-2.59%)
After-hours: Oct 8, 2026, 7:30 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $486.72 million as of October 8, 2026. It is the 14,964th most valuable company in the world and the 2,780th biggest in the United States. Its market cap has decreased by 39.16% in one year.
Market Cap
486.72M
Enterprise Value
379.85M
1-Year Change
-39.16%
Global Rank
Country Rank
#2,780 United States
Category
ChartMarket Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $486.72M, an increase of 191.45%. That is a compound annual growth rate of 19.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 423.60M | 93.60% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 478.54M |
| ProKidney | 477.67M |
| Assembly Biosciences | 463.00M |
| Ovid Therapeutics | 457.00M |
| DiaMedica Therapeutics | 454.05M |
| Entera Bio | 453.63M |
| Capricor Therapeutics | 452.32M |
| Tectonic Therapeutic | 451.79M |